Exploring Genetic Predisposition to Foetal Anticonvulsant Syndromes

  • Research type

    Research Study

  • Full title

    Exploring Genetic Predisposition to Foetal Anticonvulsant Syndromes

  • IRAS ID

    210387

  • Contact name

    Jill Clayton-Smith

  • Contact email

    jill.clayton-smith@cmft.nhs.uk

  • Sponsor organisation

    The University fo Manchester

  • Duration of Study in the UK

    0 years, 7 months, 29 days

  • Research summary

    Children exposed to antiepileptic drugs (AEDs) during pregnancy have a higher risk of medical problems at birth and with development. It is important to recognise that not all children exposed to AEDs during pregnancy have these problems and the reason why some children have and others do not have these difficulties is unclear.
    Differences in the genetic code of children exposed to AEDs during pregnancy may put some children at risk of these problems. This study will look at the genetic makeup of children with foetal anticonvulsant syndrome (FACS) and explore any link with medical or developmental problems.
    Patients with FACS will be identified through the local hospital records and database and their genetic testing will be reviewed to see any changes in the genetic code of affected children. Further cases will be identified through the Deciphering Developmental Disorders (DDD) study where more in depth genetic testing would have taken place. These results will be analysed to see any recurrent changes in genetic code which may put children at a higher risk.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    16/NW/0788

  • Date of REC Opinion

    11 Nov 2016

  • REC opinion

    Favourable Opinion